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Abstract 
Virus-encoded miRNAs are emerging as key regulators of persistent infection and host-cell 
immune evasion. Merkel cell polyomavirus (MCPyV), the predominant aetiological agent of 
Merkel cell carcinoma (MCC), encodes a single miRNA, MCV-miR-M1, which targets the 
oncogenic MCPyV large T antigen (LT). MCV-miR-M1 has previously been shown to play an 
important role in establishment of long-term infection, however, the underlying mechanism is 
not fully understood. A key unanswered question is whether, in addition to auto-regulating LT, 
MCV-miR-M1 also targets cellular transcripts to orchestrate an environment conducive for 
persistent infection. To address this, we adopted an RNA-Seq-based approach to identify 
cellular targets of MCV-miR-M1. Intriguingly, bioinformatics analysis of transcripts that are 
differentially expressed in cells expressing MCV-miR-M1 revealed several genes implicated 
in immune evasion. Subsequent target validation led to the identification of the innate 
immunity protein, SP100, as a direct target of MCV-miR-M1. Moreover, MCV-miR-M1-
mediated modulation of SP100 was associated with a significant decrease in CXCL8 secretion, 
resulting in the attenuation of neutrophil chemotaxis towards Merkel cells harbouring synthetic 
MCPyV. Based on these observations we propose that MCV-miR-M1 targets key immune 
response regulators to help facilitate persistent infection, which is a pre-requisite for cellular 
transformation in MCC.    
Introduction  
Merkel cell polyomavirus (MCPyV) is the aetiological agent in MCPyV-positive Merkel cell 
carcinoma (MCC), a rare but aggressive skin cancer that typically occurs in 
immunocompromised individuals (recently reviewed by (Grundhoff and Fischer, 2015, Liu et 
al., 2016a)). Following the discovery of MCPyV in 2008 (Feng et al., 2008), research has 
principally focused on the role of the large and small tumour antigens (LT and sT, respectively). 
To this end, the last decade has seen a dearth of studies demonstrating how LT and sT usurp or 
perturb an array of host cell mechanisms to promote virus replication, create a conducive 
environment for persistent infection and promote transformation and MCC metastasis (Abdul-
Sada et al., 2017, Arora et al., 2012, Cheng et al., 2013, Griffiths et al., 2013a, Houben et al., 
2012, Knight et al., 2015, Kwun et al., 2013, Kwun et al., 2017, Liu et al., 2011, Shuda et al., 
2008, Verhaegen et al., 2017). MCPyV-mediated attenuation of the innate immune response 
following infection and during virus replication is thought to enable a quasi-latent MCPyV 
infection in Merkel cells, an event presumed to be a pre-requisite for the development of MCC. 
Several elegant studies have demonstrated that LT and sT function to diminish the 
immunological footprint of MCPyV by targeting host innate immune components, including 
TLR9 (Shahzad et al., 2013) and the NF-κB essential modulator, NEMO (Abdul-Sada et al., 
2017, Griffiths et al., 2013a). This approach is representative of convergent and divergent 
mechanisms that have evolved in most, if not all, DNA viruses. For example, similar immune 
evasion strategies have been reported in the pathogenic human polyomaviruses, JC and BK 
(Bauman et al., 2011) and in human papillomavirus (Tummers et al., 2015). The master 
exponents of host-immune evasion are herpesviruses, which utilise a plethora of approaches to 
manipulate the host cell immune response, including; destabilisation of host cell mRNA (Rowe 
et al., 2007), proteasome-mediated degradation of host antiviral proteins (Wiertz et al., 1996) 
and derailment of host cell innate immunity (Sun et al., 2015). As is the case for MCPyV, early 
studies on herpesvirus-mediated host immune evasion centred on virus-encoded proteins, 
however, pioneering work in HCMV (Stern-Ginossar et al., 2007) followed by studies in EBV 
(Xia et al., 2008) and KSHV (Nachmani et al., 2009), rapidly established a pivotal role for 
virus-encoded miRNAs in the derailment of the host cell immune response. 
From the perspective of a virus, non-coding RNAs (ncRNA) are extremely attractive regulatory 
molecules; they take up very little genomic real estate, a single ncRNA can impact hundreds 
of cellular targets and, crucially, they are non-immunogenic. In recent years, there has been a 
significant shift in our appreciation of the prevalence and importance of virus miRNAs in the 
replication and associated pathologies of DNA viruses. Human herpesviruses from all three 
subfamilies (-, - and -) have been reported to dampen immune response via the expression 
of numerous miRNAs that target different facets of the host-immune response network (Giffin 
and Damania, 2014, Zuo et al., 2017). This strategy is not limited to the large DNA viruses, 
the pathogenic polyomaviruses BK and JC encode identical miRNAs that target and 
translationally represses the NK-receptor ligand, ULBP3, an event that is required to establish 
a persistent infection in host cells (Bauman et al., 2011). MCPyV encodes a single primary 
miRNA, that is processed to produce MCV-miR-M1-5p and MCV-miR-M1-3p (Lee et al., 
2011, Seo et al., 2009). MCV-miR-M1 is expressed from the antisense strand of the LT ORF 
and thus exhibits perfect sequence complementarity to a region in exon two of the MCPyV LT 
mRNA transcript. Indeed, MCV-miR-M1 has been shown to attenuate the expression of LT 
via dual-luciferase reporter assay (Seo et al., 2009), a function it shares with orthologous 
miRNAs encoded by the other human polyomaviruses (Imperiale, 2014).  
 
MCV-miR-M1-mediated attenuation of LT expression is believed to dampen the host cell 
immune response during polyomavirus replication, a hypothesis that is supported by studies on 
SV40 polyomavirus, where susceptibility to cytotoxic T-cells was significantly increased in 
SV40 miRNA-mutant infected cells compared with cells infected with wild type SV40 
(Sullivan et al., 2005).  Strikingly, a similar observation was recently reported for MCPyV, 
where a miRNA-deficient synthetic MCPyV loses its ability to establish long term infection 
(Theiss et al., 2015). While these observations suggest an essential role for polyomavirus 
miRNAs in host immune evasion and persistent infection, it is yet to be determined if 
polyomavirus miRNAs function solely by downregulating LT. An intriguing possibility is that, 
MCV-miR-M1, like the BK/JC miRNA, also manipulates the expression of cellular immune 
system transcripts to facilitate an environment in the host-cell that is conducive for long-term 
infection. 
To date, the only proposed cellular targets for MCV-miR-M1 were derived via in silico analysis 
of the MCV-miR-M1-5p seed sequence (Lee et al., 2011). However, a meticulous miRNA-seq-
based study of MCV-miR-M1 expression has since called into doubt the validity of these 
targets, due to a discrepancy in the seed sequence used in their identification (Theiss et al., 
2015).  Herein, we describe an unbiased RNA-seq-based analysis of MCV-miR-M1-5p and 
MCV-miR-M1-3p cellular targets. These data demonstrate that MCV-miR-M1 alters the 
expression of numerous cellular transcripts. Specifically, direct targeting of the intrinsic 
antiviral protein, SP100, during MCPyV replication leads to a reduction in the secretion of 
CXCL8 and a significant decrease in neutrophil chemotaxis towards host-cells harbouring 
replicative MCPyV. Together, these data describe a mechanism for MCV-miR-M1-mediated 
subversion of the host cell immune response that is likely to contribute to the reported role of 
MCV-miR-M1 in establishing long-term MCPyV infection in skin. 
Results  
MCV-miR-M1 downregulates the expression of numerous cellular immune transcripts. 
To determine the effect of MCV-miR-M1 expression on cellular transcript levels independently 
of other MCPyV transcripts and proteins, we developed inducible stable cell line, transient 
transfection and mimic-based in vitro expression systems for MCV-miR-M1. The comparative 
expression of MCV-miR-M1 in these different systems was assessed via stem-loop qRT-PCR 
(Figure 1a) and their functional activity against their cognate target in LT determined using 
dual-luciferase assay (DLA) (Figure 1b). As can be seen in Figure 1b, MCV-miR-M1 mimics 
exhibited increased activity against the MCV-miR-M1 cognate recognition sequence compared 
with transient transfection of an MCV-miR-M1 expression construct. This observation, in 
combination with the opportunity to dissect 5p and 3p cellular targets (an important 
consideration given the fact that the MCV-miR-M1 orthologue in JC/BK polyomavirus derails 
host-cell innate immune response via the 3p arm (Bauman et al., 2011)), prompted us to utilise 
MCV-miR-M1 mimics in our comparative expression studies. RNA-Seq analysis of MCV-
miR-M1 mimic-transfected 293 cells identified 70 and 111 cellular transcripts that showed 
significant differential expression in the presence of MCV-miR-M1-5p and MCV-miR-M1-3p, 
respectively (Table S1). Strikingly, gene annotation analysis using DAVID (Dennis et al., 
2003) revealed an overrepresentation of gene ontologies (GO) relating to regulation of cell 
communication and immune system pathways (Figure 2a). Analysis of dysregulated immune-
system transcripts produced a list of putative MCV-miR-M1 targets with proposed functional 
roles in the evasion of host-cell immune response (Figure 2b). 
MCV-miR-M1 downregulates cellular immune transcripts during MCPyV replication 
MCV-miR-M1-5p and MCV-miR-M1-3p targets identified via RNA-seq were initially 
validated by transient transfection of 293 cells with the respective MCV-miR-M1 mimic, 
followed by analysis of target transcript levels by qRT-PCR. In each instance, qRT-PCR based 
analysis corroborated our RNA-seq data, demonstrating MCV-miR-M1-5p and MCV-miR-
M1-3p specificity for several immune system-related transcripts (Figure 3a). To confirm if 
cellular targets identified via RNA-seq are also targeted by MCV-miR-M1 in the context of an 
MCPyV infection, we utilised a previously reported MCPyV replication system based on 
synthetic MCPyV genomes (MCVSyn) that are identical to prototypical field strain sequences 
(Neumann et al., 2011). Moreover, a modified MCVSyn (MCVSyn-hpko) mutated to disrupt 
the MCV-miR-M1 pre-miRNA hairpin structure (Theiss et al., 2015) served as a negative 
control. Importantly, both synthetic MCPyV genomes have been shown to undergo virus 
replication in 293 cells to produce increases in genome copy number that are detectable via 
qRT-PCR (Theiss et al., 2015). To confirm that 293 cells transfected with MCVSyn express 
functional MCV-miR-M1-5p and MCV-miR-M1-3p, stem-loop qRT-PCR (Figure 3b) and 
analysis of LT expression (Figure 3c) was carried out over a 72h period. As can be seen in 
Figure 3b, MCV-miR-M1-5p and MCV-miR-M1-3p expression was readily detected in cells 
transfected with MCVSyn, however, 293 cells transfected with MCVSyn-hpko displayed no 
detectable expression of MCV-miR-M1. Moreover, data in Figure 3c demonstrate that LT 
expression inversely correlates with expression of MCV-miR-M1, we also detected an increase 
in MCPyV genome copy number 72h post-transfection (Figure S2a), in agreement with 
previously published data characterising the MCVSyn system. We next sought to validate 
MCV-miR-M1-5p and MCV-miR-M1-3p mimic targets identified via RNA-seq in the context 
of MCPyV replication. As shown in Figure 3d, cellular transcripts identified as MCV-miR-M1 
mimic targets in our RNA-seq data set and associated with immune system GO were 
significantly down-regulated in 293 cells harbouring replicative wild type MCVSyn but not in 
293 cells transfected with MCVSyn-hpko mutant. Together these data confirm that MCV-miR-
M1 expression during MCPyV replication results in the significant decrease of several cellular 
transcripts associated with host-cell immune response. 
The antiviral innate immunity regulator, SP100, is a direct target of MCV-miR-M1-5p 
Having established that MCV-miR-M1 expression during MCPyV replication decreased the 
level of several host cell immune transcripts, we were keen to determine if any of these 
dysregulated mRNAs were direct targets of MCV-miR-M1-5p or MCV-miR-M1-3p. To 
address this, we initially carried out an in silico analysis on the 3’UTR region of each MCV-
miR-M1 target listed in Figure 2b, using RNA-hybrid (Rehmsmeier et al., 2004). Interrogation 
of RNA-hybrid data revealed putative MCV-miR-M1 seed sequence recognition sites in the 
3’UTR regions of CXCL8, RAET1G, SELPLG and SP100 (Figure 4a). To determine if 
transcripts containing putative MCV-miR-M1 seed sequence-binding sites were direct targets 
of the MCV-miR-M1, DLA assays were performed using MCV-miR-M1 mimics. As can be 
seen in Figure 4b, only the SP100 3’-UTR DLA construct exhibited a nominal but consistent 
and significant decrease in normalised luciferase signal, which was more pronounced in SP100 
3’-UTR deletions (Figure S1). This decrease was observed when the SP100 3’-UTR DLA 
construct was co-transfected with MCV-miR-M1-5p mimic or the MCVSyn genome, however, 
no decrease was observed in 293 cells co-transfected with scramble mimic, MCV-miR-M1-3p 
mimic or the MCVSyn-hpko mutant (Figure 4c), suggesting that the observed MCV-miR-M1-
dependent decrease in SP100 mRNA is due to direct targeting and translational repression of 
the SP100 transcript by MCV-miR-M1-5p. To confirm this, the putative MCV-miR-M1-5p 
recognition sequence in the SP100 3’-UTR was mutated and DLA assays repeated. Mutation 
of the putative MCV-miR-M1-5p seed sequence recognition site completely abolished MCV-
miR-M1-5p- and MCVSyn-mediated decrease of luciferase signal, confirming that the direct 
targeting of the SP100 transcript by MCV-miR-M1-5p is dependent on this region of the SP100 
3’-UTR (Figure 4d). Finally, we sought to establish if direct targeting of SP100 mRNA 
transcript by MCV-miR-M1-5p impacted on SP100 protein levels. Figure 4e clearly shows that 
SP100 protein levels are significantly reduced in cells transfected with MCV-miR-M1-5p or 
MCVSyn, compared to negative controls.  Together, these data demonstrate that SP100 is a 
direct target of MCV-miR-M1-5p and this targeting results in diminished SP100 protein levels 
during MCPyV replication. 
MCV-miR-M1-dependent decrease in SP100 modulates secretion of CXCL8  
CXCL8 plays an integral role in inducing neutrophil activation and migration in the skin in 
response to viral infection (Colditz and Watson, 1992) and is downregulated in our RNA-seq 
data set and during MCPyV replication (Figure 2a; Figure 3d). However, despite the presence 
of a putative MCV-miR-M1-3p seed sequence match in the 3’-UTR of CXCL8, DLA data 
shown in Figure 4b suggest that the effect of MCV-miR-M1 on the CXCL8 transcript level is 
indirect. Despite the indirect nature of MCV-miR-M1-induced CXCL8 transcript changes, 
given the importance of CXCL8 in the antiviral response in skin we were eager to determine if 
this resulted in diminished secretion of CXCL8. To address this question, conditioned media 
was collected from TNF-α stimulated 293 cells 24h post-transfection with mimics and 
unstimulated 293 cells transfected with either MCVSyn or MCVSyn-hpko genomes and 
CXCL8 secretion analysed via ELISA. We observed significantly reduced levels of CXCL8 in 
media collected from TNF-α-stimulated 293 cells transfected with both MCV-miR-M1-5p and 
MCV-miR-M1-3p mimics, compared with scramble mimic control (Figure 5a). CXCL8 levels 
were also significantly lower in 293 cells harbouring the wild type MCVSyn, compared with 
cells transfected with the MCVSyn-hpko miRNA mutant (Figure 5b).  
The observation that MCV-miR-M1-5p mimic attenuated CXCL8 secretion is intriguing, as 
we did not observe any decrease in CXCL8 transcript levels in 293 cells transfected with this 
arm of the virus miRNA, either via RNA-seq (Table S1) or qRT-PCR (Figure 6a). A possible 
explanation for this is that MCV-miR-M1-5p mediated reduction in SP100 expression impacts 
on CXCL8 secretion. While there is evidence to support a role for PML-bodies in the regulation 
of cytokine gene expression (Ohgiya et al., 2012), there is no evidence to support a direct role 
for SP100 in regulating CXCL8 expression. To test if observed decreases in secreted CXCL8 
in 293 cells transfected with MCV-miR-M1-5p were related to the 5p-mediated decrease in 
SP100 protein expression the open reading frame of SP100 lacking the endogenous 3’-UTR 
was PCR cloned to generate pCDNA-SP100. Co-transfection of 293 cells with pCDNA-SP100 
and either MCV-miR-M1-5p or MCVSyn prevented MCV-miR-M1-mediated downregulation 
of SP100 protein (Figure 5c) and led to the partial rescue of CXCL8 secretion, compared with 
MCV-miR-M1-3p or negative controls (Figures 5d and 5e). Together these data demonstrate 
that there is an MCV-miR-M1-dependent decrease in CXCL8 secretion during MCPyV 
replication and that this reduction is mediated in part via direct targeting of SP100 by MCV-
miR-M1-5p. 
Diminished migration of neutrophils towards cells harbouring MCPyV.  
CXCL8 is a neutrophil chemoattractant and activator (Baggiolini et al., 1989, Harada et al., 
1994) that modulates neutrophil migration (Huber et al., 1991) and is an important component 
of the innate immune response to virus infection in skin (de Oliveira et al., 2016). To establish 
if MCV-miR-M1-dependent downregulation of CXCL8 during MCPyV replication is 
significant in terms of attenuating neutrophil chemotaxis, trans-well migration assays were 
performed. Neutrophil migration was significantly impaired towards conditioned media from 
both MCV-miR-M1-5p and -3p mimic transfected and MCVSyn-transfected cells compared 
with controls (Figure 5f), suggesting that MCV-miR-M1 negatively regulates neutrophil 
migration, in vitro, towards cells harbouring replicative MCPyV. To investigate if migration 
was due to attenuation of CXCL8 levels, neutrophil migration assays were repeated in the 
presence or absence of the CXCR2 antagonist, SB265610, which has been reported to block 
CXCL8-induced neutrophil migration in vitro and in vivo (Bradley et al., 2009). Treatment 
with SB265610 resulted in significant downregulation of neutrophil migration for both 
MCVSyn- and MCVSyn-hpko-transfected cells (Figure 5g). This reduction was more 
pronounced in MCVSyn-transfected cells, where MCV-miR-M1 induces CXCL8 
downregulation. These data suggest that MCV-miR-M1 mediates downregulation of neutrophil 
migration during virus replication at least in part via modulation of CXCL8 secretion. 
MCV-miR-M1 targets SP100 and CXCL8 secretion in MCC cell lines resulting in 
attenuated neutrophil migration. 
Thus far data was obtained using the 293 cell line, which has been previously shown to 
facilitate the study of MCPyV virus-host cell interactions (Griffiths et al., 2013b, Kwun et al., 
2015, Wang et al., 2012) and act as a semi-permissive cell line for the MCVSyn system 
(Neumann et al., 2011). However, given the proposed function of MCV-miR-M1 in the 
establishment of persistent infection and our data suggesting that this might be achieved in part 
via the dysregulation of SP100 and CXCL8 secretion we were keen to demonstrate that MCV-
miR-M1 functions in the same manner in Merkel cells, where quasi-latency is hypothesised to 
be a functional prerequisite for transformation. Merkel cells have been cultured in vitro 
alongside keratinocytes (Fradette et al., 2003), however, no Merkel cell-specific tissue culture 
system is currently available. Therefore, to study MCV-miR-M1 in a Merkel cell background 
we utilised the MCPyV-negative MCC cell line, MCC13 and the MCPyV-positive cell line, 
MKL-1, which has been reported to be a representative model for MCC (Daily et al., 2015). 
MCC13 cells were transfected with MCV-miR-M1-5p, MCV-miR-M1-3p and scramble mimic 
control and an analysis of SP100 and CXCL8 transcript and protein expression carried out, as 
described above. We detected significant changes in both SP100 and CXCL8 mRNA (Figure 
6a) and protein levels (Figures 6b and 6c) that were consistent with data gathered using 293 
cells. Moreover, neutrophil migration was also significantly reduced in both MCC cell lines 
expressing MCV-miR-M1 mimics (Figure 6d). These data confirm that MCV-miR-M1 
modulates the expression of SP100 and CXCL8 in two MCC cell lines, resulting in reduced 
migration of neutrophils towards Merkel cells harbouring synthetic MCPyV genomes. 
Discussion 
Despite mounting evidence describing virus-encoded miRNAs as key regulators of host cell 
transcripts (Kincaid and Sullivan, 2012) for many virus miRNAs there is a lack of global target 
identification. Currently, there are no published data describing validated cellular targets of 
MCV-miR-M1. Using an unbiased RNA-seq-based approach we have identified numerous 
MCV-miR-M1-modulated cellular transcripts, including SP100, which is a constituent of 
Promyelocytic leukaemia protein-nuclear bodies (PML-NB), a nuclear protein complex 
involved in the regulation of transcription, apoptosis, cell cycle, response to stress and hormone 
signalling and development. While our RNA-seq data identified various cellular targets, many 
of which are involved in immune related processes, it is important to acknowledge that given 
the HEK293-cell background it is possible that some relevant targets were missed.  
SP100 is an intriguing MCV-miR-M1 target, which has been implicated in the innate immune 
response against dsDNA viruses, including MCPyV (Gunther et al., 2014, Jiang et al., 2011, 
Neumann et al., 2016, Tavalai and Stamminger, 2009, Wagenknecht et al., 2015) and has been 
shown to be downregulated during MCPyV replication, although no mechanism for this was 
reported (Neumann et al., 2016). Our data suggest that MCV-miR-M1 mediates (at least in 
part) the observed downregulation of SP100 in cells harbouring synthetic MCPyV. The 
argument for MCV-miR-M1 mediated downregulation, rather than modulation by one of the 
MCPyV proteins is strengthened by the fact that SP100 levels are not decreased in cells 
transfected with MCVSyn-hpko, which lacks MCV-miR-M1 expression but exhibits 
significantly increased expression of LT, sT and VP1 (Figures 3c and 4e and (Theiss et al., 
2015).  
A caveat of the MCV-hpko mutant in terms of its use as a negative control is that loss of MCV-
miR-M1 expression results in increased levels of LT that may contribute to some of the 
observed effects. The use of MCV-miR-M1 mimics alongside MCVSyn has enabled us to 
corroborate putative MCV-miR-M1-specific effects observed using the synthetic virus in the 
absence of other MCPyV transcripts and proteins. While we consistently observed similar 
results between MCV-miR-M1 mimics and MCVSyn, we cannot rule out that elevated LT 
expression in MCVSyn-hpko cells may be contributing to some of our observations, in 
particular changes in CXCL8 secretion, where LT has been shown to increase CXCL8 
expression (Richards et al., 2015). However, mimic data suggest that MCV-miR-M1 can 
significantly impair CXCL8 expression in the absence of LT (Figure 5a). 
Our understanding of how PML-NBs and SP100 contribute to the antiviral response has 
improved in recent years (Nisole et al., 2013), however, mechanistically there is much still to 
unpick. Here we have shown that direct targeting of SP100 by MCV-miR-M1 modulates 
CXCL8 secretion. It has been reported that PML functions to regulate the expression of 
proinflammatory cytokines, including IL-6 and CXCL8 (Lunardi et al., 2011), however, it is 
not known if SP100 is also able to function in this manner. One explanation may be that SP100 
is able to transcriptionally regulate CXCL8 either directly or in trans, a notion supported by 
previous work demonstrating that SP100 functions to activate ETS-family transcription factors 
(Wasylyk et al., 2002). However, as MCV-miR-M1-5p induces changes in secreted CXCL8, 
but does not alter CXCL8 transcript levels (Table S1 and Figure 6a), it seems more likely that 
MCV-miR-M1-5p-dysregulation of SP100 (or other unidentified cellular transcripts) impact 
on CXCL8 via a post-translational mechanism. Indeed, our observation that ectopic expression 
of pCDNA-SP100 only partially rescues the MCV-miR-M1-5p mediated reduction of CXCL8 
secretion strongly suggests that other MCV-miR-M1 dysregulated factors are influencing 
CXCL8 secretion and presumably, in turn, neutrophil migration. Trans-well assays support this 
hypothesis, as both 5p and 3p MCV-miR-M1 mimics diminished neutrophil chemotaxis to a 
similar level, despite MCV-miR-M1-3p having no effect on SP100 mRNA or protein levels. 
We are currently investigating if other indirect MCV-miR-M1 targets impair neutrophil 
migration during MCPyV replication. 
The functional significance of MCV-miR-M1-mediated attenuation of neutrophil chemotaxis 
for MCPyV remains to be established. One possibility that has been reported in -herpesviruses 
(Zhu et al., 2013) and previously discussed for MCPyV (Theiss et al., 2015) is that by reducing 
the immunological footprint of MCPyV during replication the virus is more likely to establish 
a quasi-latent infection. Such a mechanism might explain how MCPyV is able to infect Merkel 
cells for a duration of time that permit rare MCPyV-genome integration events and subsequent 
transformation and development of MCC, although the absence of a non-transformed Merkel 
cell culture system makes this theory difficult to test. Recently, dermal fibroblasts were 
identified as the likely primary host cell type naturally and productively infected by MCPyV 
(Liu et al., 2016b). We are currently investigating MCV-miR-M1-mediated attenuation of 
neutrophil chemotaxis in these cells and it will be of interest to determine how this impacts on 
commensal MCPyV infection in skin. In summary, we have employed an unbiased, RNA-seq 
based approach to identify cellular MCV-miR-M1 targets and shown that the innate immune 
response protein, SP100 is a direct target of MCV-miR-M1-5p. Furthermore, we have 
demonstrated that there is a MCV-miR-M1-dependent decrease in neutrophil migration that 
may be contributing to the host cell immune evasion strategy of MCPyV following infection 
of Merkel cells.   
Materials & Methods 
Tissue culture 
Cells were purchased from ECACC and certified mycoplasma-free. 293 and Flp-In™ T-REx™ 
293-MCVmiR were maintained in DMEM media supplemented with 10% FBS, 100 U/ml of 
penicillin and 100 µg/ml of streptomycin. MCC13 and MKL1 cells were maintained in RPMI 
1640 media supplemented with 10% FBS, 100 U/ml of penicillin and 100 µg/ml of 
streptomycin. All cells were cultured at 37˚C and 5% CO2 and transfected using Lipofectamine 
3000 as described (Boyne et al., 2010). 
RNA sequencing (RNA-Seq) 
293 cells were transfected with either MCV-miR-M1-5p, MCV-miR-M1-3p or control mimic 
(Thermo Fisher Scientific) prior to RNA extraction and confirmation of MCV miRNA 5p and 
3p expression via stem loop qRT-PCR. Total RNA libraries were prepared using TruSeq 
Stranded Total RNA Sample Prep Kit (Illumina, USA) and the TruSeq cDNA libraries were 
analysed via Illumina HiSeq2500 paired end 100bp. Differential gene expression and gene 
annotation analysis were carried out using edgeR software and DAVID annotation tool, 
respectively. RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI 
(www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-6526. 
qRT-PCR 
Total RNA was extracted from cells and 500ng used to generate cDNA prior to qRT-PCR 
analysis using SsoAdvanced SYBR master mix (Bio-Rad, UK) on the CFX96 system (Bio-
Rad, UK).  
Stem loop qRT-PCR was carried out to detect MCV miRNA (Czimmerer et al., 2013). Briefly, 
stem loop cDNA was generated using a stem loop primer containing a MCV miRNA specific 
hexamer sequence. A forward primer complementary to MCV miRNA and a universal reverse 
primer were used to detect miRNA expression via qRT-PCR. qRT-PCR analysis of MCPyV 
genome copy number was performed as previously described (Theiss et al., 2015). A list of 
oligonucleotides used during this study can be found in Table S2. 
Protein analysis 
Human CXCL8 ELISA (eBioscience) was carried out as previously described (Bridgewood et 
al., 2017). SDS-PAGE and western blot analysis were performed as described (Schumann et 
al., 2016). Anti-SP100 and anti-LT (CM2B4) (Santa Cruz) were used at a dilution of 1:1000, 
GAPDH (Abcam) was used at a dilution of 1:10000.  
Dual luciferase assay 
psiCHECK-2 expression construct was generated by inserting the respective 3’UTR response 
element downstream of Renilla luciferase (hRluc) gene. 293 cells were co-transfected with 
psiCHECK-2/3’UTR of interest and MCV miRNA mimics, control mimic or MCVSyn 
genomes, prior to Dual luciferase assay (DLA). 
Neutrophil isolation and migration assay 
Neutrophils were isolated from peripheral blood as previously described (Lau and Hunstad, 
2013). In vitro neutrophil migration was measured using transwell chambers. Briefly, 
neutrophils were seeded into the top chamber and cell supernatants were placed in the lower 
chamber. Plates were incubated at 37ºC and 5% CO2 for two hours prior to mixing the lower 
chamber contents with equal volume of CellTiter-Glo® 2.0 (Promega) and recording 
luminescence using a TECAN infinite M200 plate reader. 
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Figure 1: Comparative analysis of MCV-miR-M1 expression systems. 
Total RNA was extracted from doxycycline-induced MCV-miR-M1-293 cells and 293 cells 
transiently transfected with either pCDNA3.1-MCV-miR-M1 or MCV-miR-M1 mimics and 
cDNA generated prior to analysis of MCV-miR-M1-5p and MCV-miR-M1-3p expression via 
stem-loop qPCR, n=3 (a). 293 cells were co-transfected with either psiCHECK2 harbouring 
the cognate MCV-miR-M1 recognition sequence or a mutated control sequence alongside 
pCDNA3.1-MCV-miR-M1 or MCV-miR-M1 mimics and DLA performed to determine 
relative miRNA activity, n=3 (b). 
Figure 2: MCV-miR-M1 preferentially dysregulates cellular immune-response 
transcripts. 
RNA-seq was performed on total RNA extracted from 293 cells that had either been transfected 
in biological triplicate with scramble miRNA mimic, MCV-miR-M1-5p mimic or MCV-miR-
M1-3p mimic. Analysis of differential expression of cellular transcripts by edgeR and 
subsequent gene ontology analysis using DAVID (a) identified a set of cellular transcripts that 
were significantly dysregulated by MCV-miR-M1 and involved in immune response (b).  
Figure 3: MCV-miR-M1 targets immune-response targets during MCPyV replication. 
293 cells were transiently transfected with MCV-miR-M1-5p, MCV-miR-M1-3p or scramble 
mimic control and expression of target transcript determined via qRT-PCR, n=3 (a). 293 cells 
were transfected with MCVSyn or MCVSyn-hpko genomes and total RNA and protein 
extracted 24h, 48h and 72h post-transfection for analysis of MCV-miR-M1-5p and MCV-miR-
M1-3p expression via stem-loop qRT-PCR (b) and LT expression by immunoblot (c), n=3. 293 
cells were transfected with either MCVSyn of MCVSyn-hpko genomes and cultured for 72h 
prior to total RNA extraction and analysis of MCV-miR-M1 target expression by qRT-PCR, 
n=3 (d).  
Figure 4: MCV-miR-M1 directly targets the viral innate immune response protein, 
SP100. 
Full-length 3’UTRs of each validated target were analysed using RNA-hybrid to identify 
putative seed-sequence binding sites for MCV-miR-M1 (a). The full length 3’UTR regions of 
CXCL8, RAET1G, SELPLG and SP100 were PCR-amplified and cloned downstream of 
Renilla luciferase DLA assays performed via co-transfection of 293 cells with each 
recombinant 3’-UTR construct and either scramble control, MCV-miR-M1-5p or MCV-miR-
M1-3p mimic, n=3 (b). DLA assays carried out via co-transfection of 293 cells with scramble 
control mimic, MCV-miR-M1-5p mimic, MCV-miR-M1-3p mimic, MCVSyn or MCVSyn-
hpko and either wild-type SP100 3’-UTR (c) or the mutant SP100 3’-UTR (d), n=3. 293 cells 
were transfected with either scramble mimic control, MCV-miR-M1-5p mimic, MCV-miR-
M1-3p mimic, MCVSyn or MCVSyn-hpko and cultured for 48h prior to isolation of total 
protein and analysis by immunoblot, n=3 (e).  
Figure 5: MCV-miR-M1 mediates a reduction in the secretion of CXCL8 that impairs 
neutrophil chemotaxis. 
Conditioned media was collected 24h post-transfection from TNF-α stimulated 293 cells 
transfected with either scramble mimic, MCV-miR-M1-5p mimic or MCV-miR-M1-3p mimic 
and relative CXCL8 levels determined via ELISA, n=3 (a). 293 cells were transfected with 
either MCVSyn or MCVSyn-hpko genomes (in the absence of TNF-) and conditioned media 
collected 72h post-transfection for analysis of CXCL8 secretion via ELISA, n=3 (b). 293 cells 
were treated as described in (a) and (b) above with the addition of either pCDNA3.1 (-) or 
pcDNA-SP100 (SP100) to the transfection mix. Total protein was isolated and SP100 
expression assessed via immunoblot (c), alongside this, conditioned media was collected for 
analysis of CXCL8 secretion via ELISA (d and e), n=3. 293 cells were stimulated with TNF-α 
prior to transfection with either scramble mimic, MCV-miR-M1-5p mimic or MCV-miR-M1-
3p and cultured for 24h before isolating conditioned growth media, alongside these 293 cells 
were also transfected with MCVSyn or MCVSyn-hpko and cultured for 72h prior to collection 
of conditioned growth media. Both sets of conditioned media obtained above were then used 
in neutrophil chemotaxis trans-well migration assay, n=3 (f). 293 cells were transfected with 
MCVSyn or MCVSyn-hpko in the presence or absence of SB265610 and cultured for 72h prior 
to collection of conditioned growth media and neutrophil chemotaxis trans-well migration 
assay, n=3 (g). 
Figure 6: MCV-miR-M1 mediated attenuation of CXCL8 secretion and neutrophil 
chemotaxis also occurs in Merkel cells. 
MCC13 or MKL-1 cells were transfected with either scramble mimic, MCV-miR-M1-5p 
mimic or MCV-miR-M1-3p mimic and cultured for 24h before isolating total RNA for analysis 
of CXCL8 and SP100 transcripts levels via qRT-PCR, n=3 (a), total protein isolation for the 
analysis of SP100 expression by immunoblot, n=3 (b). MCC13 or MKL-1 cells were stimulated 
with TNF-α prior to transfection with either scramble mimic, MCV-miR-M1-5p mimic or 
MCV-miR-M1-3p and cultured for 24h before the collection of conditioned growth media and 
analysis of secreted CXCL8 levels via ELISA, n=3 (c) and neutrophil chemotaxis by trans-well 
migration assay, n=3 (d).  
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